ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Deficiency in Men
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 215922" data-attributes="member: 13851"><p><strong>Table 5 Monitoring of Testosterone Replacement Therapy</strong></p><p><strong>[ATTACH=full]19250[/ATTACH]</strong></p><p><strong>Abbreviations: DRE = digital rectal examination; PSA = prostate-specific antigen. </strong></p><p><strong></strong></p><p><strong>Standardized plan for the monitoring of testosterone replacement therapy. Because prostate monitoring has the potential for harm, the decision to screen patients for prostate cancer risk and institute PSA monitoring should be made jointly by the clinician and the patient. Expert opinions and local practices on PSA screening and monitoring vary. <u>After 1 year of testosterone treatment, prostate monitoring should conform to the guidelines for prostate cancer screening, depending on the race and age of the patient</u>.</strong></p></blockquote><p></p>
[QUOTE="madman, post: 215922, member: 13851"] [B]Table 5 Monitoring of Testosterone Replacement Therapy [ATTACH type="full"]19250[/ATTACH] Abbreviations: DRE = digital rectal examination; PSA = prostate-specific antigen. Standardized plan for the monitoring of testosterone replacement therapy. Because prostate monitoring has the potential for harm, the decision to screen patients for prostate cancer risk and institute PSA monitoring should be made jointly by the clinician and the patient. Expert opinions and local practices on PSA screening and monitoring vary. [U]After 1 year of testosterone treatment, prostate monitoring should conform to the guidelines for prostate cancer screening, depending on the race and age of the patient[/U].[/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Deficiency in Men
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top